{
  "DOI": "10.1007/s10689-016-9942-0",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-016-9942-0",
  "alternative-id": [
    "9942"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Evans",
      "given": "D. G.",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Woodward",
      "given": "E. R.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Howell",
      "given": "S. J.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Verhoef",
      "given": "S.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Howell",
      "given": "A.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lalloo",
      "given": "F.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2016,
        10,
        31
      ]
    ],
    "date-time": "2016-10-31T10:09:46Z",
    "timestamp": 1477908586000
  },
  "deposited": {
    "date-parts": [
      [
        2017,
        6,
        25
      ]
    ],
    "date-time": "2017-06-25T02:26:01Z",
    "timestamp": 1498357561000
  },
  "indexed": {
    "date-parts": [
      [
        2022,
        4,
        4
      ]
    ],
    "date-time": "2022-04-04T08:31:09Z",
    "timestamp": 1649061069956
  },
  "is-referenced-by-count": 2,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "2",
  "issued": {
    "date-parts": [
      [
        2016,
        10,
        31
      ]
    ]
  },
  "journal-issue": {
    "issue": "2",
    "published-print": {
      "date-parts": [
        [
          2017,
          4
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://creativecommons.org/licenses/by/4.0",
      "content-version": "unspecified",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2016,
            10,
            31
          ]
        ],
        "date-time": "2016-10-31T00:00:00Z",
        "timestamp": 1477872000000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-016-9942-0.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-016-9942-0/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-016-9942-0.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "173-179",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2016,
        10,
        31
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2016,
        10,
        31
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2017,
        4
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1200/JCO.2002.09.023",
      "author": "SR Lakhani",
      "doi-asserted-by": "crossref",
      "first-page": "2310",
      "issue": "9",
      "journal-title": "J Clin Oncol",
      "key": "9942_CR1",
      "unstructured": "Lakhani SR, Van De Vijver MJ, Jacquemier J et al (2002) The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. J Clin Oncol 20(9):2310–2318",
      "volume": "20",
      "year": "2002"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-04-2424",
      "author": "SR Lakhani",
      "doi-asserted-by": "crossref",
      "first-page": "5175",
      "issue": "14",
      "journal-title": "Clin Cancer Res",
      "key": "9942_CR2",
      "unstructured": "Lakhani SR, Reis-Filho JS, Fulford L et al (2005) Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype. Clin Cancer Res 11(14):5175–5180",
      "volume": "11",
      "year": "2005"
    },
    {
      "DOI": "10.1186/s13058-014-0474-y",
      "author": "AB Spurdle",
      "doi-asserted-by": "crossref",
      "first-page": "3419",
      "issue": "6",
      "journal-title": "Breast Cancer Res",
      "key": "9942_CR3",
      "unstructured": "Spurdle AB, Couch FJ, Parsons MT et al (2014) Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia. Breast Cancer Res 16(6):3419",
      "volume": "16",
      "year": "2014"
    },
    {
      "DOI": "10.1136/bmj.f3829",
      "author": "DG Evans",
      "doi-asserted-by": "publisher",
      "first-page": "f3829",
      "issue": "346",
      "journal-title": "BMJ",
      "key": "9942_CR4",
      "unstructured": "Evans DG, Graham J, O’Connell S, Arnold S, Fitzsimmons D (2013) Familial breast cancer: summary of updated NICE guidance. BMJ 25(346):f3829. doi: 10.1136/bmj.f3829",
      "volume": "25",
      "year": "2013"
    },
    {
      "DOI": "10.1086/301670",
      "author": "G Parmigiani",
      "doi-asserted-by": "crossref",
      "first-page": "145",
      "journal-title": "Am J Human Genet",
      "key": "9942_CR5",
      "unstructured": "Parmigiani G, Berry DA, Aquilar O (1998) Determining carrier probabilities for breast cancer susceptibility genes BRCA1 and BRCA2. Am J Human Genet 62:145–148",
      "volume": "62",
      "year": "1998"
    },
    {
      "DOI": "10.1038/sj.bjc.6604411",
      "author": "AC Antoniou",
      "doi-asserted-by": "crossref",
      "first-page": "2015",
      "issue": "12",
      "journal-title": "Br J Cancer",
      "key": "9942_CR6",
      "unstructured": "Antoniou AC, Cunningham AP, Peto J et al (2008) The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer 98(12):2015",
      "volume": "98",
      "year": "2008"
    },
    {
      "DOI": "10.1002/sim.1668",
      "author": "J Tyrer",
      "doi-asserted-by": "crossref",
      "first-page": "1111",
      "issue": "7",
      "journal-title": "Stat Med",
      "key": "9942_CR7",
      "unstructured": "Tyrer J, Duffy SW, Cuzick J (2004) A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 23(7):1111–1130",
      "volume": "23",
      "year": "2004"
    },
    {
      "DOI": "10.1136/jmg.2003.017996",
      "author": "DG Evans",
      "doi-asserted-by": "crossref",
      "first-page": "474",
      "issue": "6",
      "journal-title": "J Med Genet",
      "key": "9942_CR8",
      "unstructured": "Evans DG, Eccles DM, Rahman N et al (2004) A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO. J Med Genet 41(6):474–480",
      "volume": "41",
      "year": "2004"
    },
    {
      "DOI": "10.1200/JCO.2002.20.6.1480",
      "author": "TS Frank",
      "doi-asserted-by": "crossref",
      "first-page": "1480",
      "issue": "6",
      "journal-title": "J Clin Oncol",
      "key": "9942_CR9",
      "unstructured": "Frank TS, Deffenbaugh AM, Reid JE et al (2002) Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 20(6):1480–1490",
      "volume": "20",
      "year": "2002"
    },
    {
      "DOI": "10.1136/jmg.2009.067850",
      "author": "DG Evans",
      "doi-asserted-by": "crossref",
      "first-page": "811",
      "issue": "12",
      "journal-title": "J Med Genet",
      "key": "9942_CR10",
      "unstructured": "Evans DG, Lalloo F, Cramer A et al (2009) Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for BRCA1 and BRCA2 testing. J Med Genet 46(12):811–817",
      "volume": "46",
      "year": "2009"
    },
    {
      "DOI": "10.1186/bcr2576",
      "author": "N Mavaddat",
      "doi-asserted-by": "crossref",
      "first-page": "R28",
      "issue": "3",
      "journal-title": "Breast Cancer Res",
      "key": "9942_CR11",
      "unstructured": "Mavaddat N, Rebbeck TR, Lakhani SR, Easton DF, Antoniou AC (2010) Incorporating tumor pathology information into breast cancer risk prediction algorithms. Breast Cancer Res 12(3):R28",
      "volume": "12",
      "year": "2010"
    },
    {
      "DOI": "10.1038/bjc.2013.730",
      "author": "AJ Lee",
      "doi-asserted-by": "crossref",
      "first-page": "535",
      "issue": "2",
      "journal-title": "Br J Cancer",
      "key": "9942_CR12",
      "unstructured": "Lee AJ, Cunningham AP, Kuchenbaecker KB, Mavaddat N, Easton DF, Antoniou AC, Consortium of Investigators of Modifiers of BRCA1/2; Breast Cancer Association Consortium (2014) BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumor pathology and web interface. Br J Cancer 110(2):535–545",
      "volume": "110",
      "year": "2014"
    },
    {
      "DOI": "10.1136/jmedgenet-2012-101415",
      "author": "C Fischer",
      "doi-asserted-by": "crossref",
      "first-page": "360",
      "issue": "6",
      "journal-title": "J Med Genet",
      "key": "9942_CR13",
      "unstructured": "Fischer C, Kuchenbäcker K, Engel C et al (2013) Evaluating the performance of the breast cancer genetic risk models BOADICEA, IBIS, BRCAPRO and claus for predicting BRCA1/2 mutation carrier probabilities: a study based on 7352 families from the German hereditary breast and ovarian cancer consortium. J Med Genet 50(6):360–367",
      "volume": "50",
      "year": "2013"
    },
    {
      "DOI": "10.1158/1055-9965.EPI-11-0775",
      "author": "N Mavaddat",
      "doi-asserted-by": "crossref",
      "first-page": "134",
      "issue": "1",
      "journal-title": "Cancer Epidemiol Biomark Prev",
      "key": "9942_CR14",
      "unstructured": "Mavaddat N, Barrowdale D, Andrulis IL et al (2012) Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the consortium of investigators of modifiers of BRCA1/2 (CIMBA). Cancer Epidemiol Biomark Prev 21(1):134–147",
      "volume": "21",
      "year": "2012"
    },
    {
      "DOI": "10.1200/JCO.2014.57.1414",
      "author": "FJ Couch",
      "doi-asserted-by": "crossref",
      "first-page": "304",
      "issue": "4",
      "journal-title": "J Clin Oncol",
      "key": "9942_CR15",
      "unstructured": "Couch FJ, Hart SN, Sharma P et al (2015) Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer. J Clin Oncol 33(4):304–311",
      "volume": "33",
      "year": "2015"
    },
    {
      "DOI": "10.1038/bjc.2012.31",
      "author": "L Robertson",
      "doi-asserted-by": "crossref",
      "first-page": "1234",
      "issue": "6",
      "journal-title": "Br J Cancer",
      "key": "9942_CR16",
      "unstructured": "Robertson L, Hanson H, Seal S et al (2012) BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years. Br J Cancer 106(6):1234–1238",
      "volume": "106",
      "year": "2012"
    },
    {
      "DOI": "10.1136/jmedgenet-2011-100006",
      "author": "DG Evans",
      "doi-asserted-by": "crossref",
      "first-page": "520",
      "issue": "8",
      "journal-title": "J Med Genet",
      "key": "9942_CR17",
      "unstructured": "Evans DG, Howell A, Ward D, Lalloo F, Jones JL, Eccles DM (2011) Prevalence of BRCA1 and BRCA2 mutations in triple negative breast cancer. J Med Genet 48(8):520–522",
      "volume": "48",
      "year": "2011"
    },
    {
      "DOI": "10.1136/jmedgenet-2013-101607",
      "author": "SL Ingham",
      "doi-asserted-by": "crossref",
      "first-page": "368",
      "issue": "6",
      "journal-title": "J Med Genet",
      "key": "9942_CR18",
      "unstructured": "Ingham SL, Warwick J, Buchan I et al (2013) Ovarian cancer among 8005 women from a breast cancer family history clinic: no increased risk of invasive ovarian cancer in families testing negative for BRCA1 and BRCA2. J Med Genet 50(6):368–372",
      "volume": "50",
      "year": "2013"
    },
    {
      "DOI": "10.1007/s10549-012-2130-5",
      "author": "MJ Smith",
      "doi-asserted-by": "crossref",
      "first-page": "895",
      "issue": "2",
      "journal-title": "Breast Cancer Res Treat",
      "key": "9942_CR19",
      "unstructured": "Smith MJ, Gifford FL, Lalloo F, Newman WG, Evans DG (2012) High sensitivity for BRCA1/2 mutations in breast/ovarian kindreds: are there still other breast/ovary genes to be discovered? Breast Cancer Res Treat 134(2):895–897",
      "volume": "134",
      "year": "2012"
    },
    {
      "DOI": "10.1136/jmg.40.11.807",
      "author": "E Amir",
      "doi-asserted-by": "crossref",
      "first-page": "807",
      "issue": "11",
      "journal-title": "J Med Genet",
      "key": "9942_CR20",
      "unstructured": "Amir E, Evans DG, Shenton A, Lalloo F, Moran A, Boggis C, Wilson M, Howell A (2003) Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. J Med Genet 40(11):807–814",
      "volume": "40",
      "year": "2003"
    },
    {
      "DOI": "10.1136/jmg.2010.078113",
      "author": "JR Wilson",
      "doi-asserted-by": "crossref",
      "first-page": "771",
      "issue": "11",
      "journal-title": "J Med Genet",
      "key": "9942_CR21",
      "unstructured": "Wilson JR, Bateman AC, Hanson H et al (2010) A novel HER2-positive breast cancer phenotype arising from germline TP53 mutations. J Med Genet 47(11):771–774",
      "volume": "47",
      "year": "2010"
    },
    {
      "DOI": "10.1200/JCO.2014.59.5728",
      "author": "G Bougeard",
      "doi-asserted-by": "crossref",
      "first-page": "2345",
      "issue": "21",
      "journal-title": "J Clin Oncol",
      "key": "9942_CR22",
      "unstructured": "Bougeard G, Renaux-Petel M, Flaman JM et al (2015) Revisiting Li-Fraumeni syndrome from TP53 mutation carriers. J Clin Oncol 33(21):2345–2352",
      "volume": "33",
      "year": "2015"
    },
    {
      "DOI": "10.1093/jnci/djt134",
      "author": "E Copson",
      "doi-asserted-by": "crossref",
      "first-page": "978",
      "issue": "13",
      "journal-title": "J Natl Cancer Inst",
      "key": "9942_CR23",
      "unstructured": "Copson E, Eccles B, Maishman T et al (2013) Prospective observational study of breast cancer treatment outcomes for UK women aged 18–40 years at diagnosis: the POSH study. J Natl Cancer Inst 105(13):978–988",
      "volume": "105",
      "year": "2013"
    }
  ],
  "reference-count": 23,
  "references-count": 23,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-016-9942-0"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Risk algorithms that include pathology adjustment for HER2 amplification need to make further downward adjustments in likelihood scores"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "16"
}